RA Capital Management Reduces Stake in VOR Biopharma

RA Capital Management, L.P., along with Peter Kolchinsky and Rajeev Shah, filed Amendment No. 8 to their Schedule 13D/A for VOR Biopharma Inc. The amendment reports the sale of shares by RA Capital Healthcare Fund, L.P. in multiple transactions between October 21, 2025, and October 27, 2025. The shares were sold at weighted average prices ranging from $28.00 to $28.475. The Reporting Persons collectively own 17.3% of VOR Biopharma's common stock, including shares held directly and through warrants. The amendment also includes details on the beneficial ownership and voting power of the Reporting Persons. No other significant changes were reported in this amendment.